Number of the records: 1
dihydroxyfenylalanín
SYS d004295 LBL 00000cz--a2200000o--4500 005 20250606213929.3 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.092.311.200 065 $a D02.455.426.559.389.657.166.175.200 065 $a D12.125.072.050.685.400 065 $a D12.125.072.050.875.130 066 $a 01 $c 03 150 $a dihydroxyfenylalanín $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Dopa $2 eng 450 $w v $a DOPA $2 slo 450 $w v $a 3-(3,4-dihydroxyfenyl)alanín $2 slo 450 $w v $a 3-hydroxytyrozín $2 slo 550 $7 sllk_us_auth*d015259 $Y Dopamine Agents $w P $a látky dopamínové 550 $7 sllk_us_auth*d004296 $Y Dopa Decarboxylase $w p $a dopadekarboxyláza 550 $7 sllk_us_auth*d004298 $Y Dopamine $w p $a dopamín 665 $a 2002(1966); for BETA-HYDROXYTYROSINE use DIHYDOXYPHENYLALANINE (NM) 1989-1991 $2 eng 680 9-
$i A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. $2 eng 680 $a check text to see if LEVODOPA; (L-DOPA); is not meant instead $2 eng 750 -2
$a Dihydroxyphenylalanine $2 eng 980 $x M
Number of the records: 1